These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 32168920)

  • 1. Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.
    Li H; Guo M; An Z; Meng J; Jiang J; Song J; Wu W
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32168920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
    Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
    Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of triglyceride-glucose-waist circumference with metabolic associated fatty liver disease and the severity of liver steatosis and fibrosis in American adults: a population-based study.
    Wu Z; Huang K; Bao S; Zhang X; Li J; Kong W; Shi Y; Xie Y
    Scand J Gastroenterol; 2024 May; 59(5):561-569. PubMed ID: 38235548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].
    Xia B; He H; Qin K; Li SQ; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):591-595. PubMed ID: 37248589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waist circumference, body mass index, serum uric acid, blood sugar, and triglyceride levels are important risk factors for abnormal liver function tests in the Taiwanese population.
    Hsieh MH; Lin WY; Chien HH; Chien LH; Huang CK; Yang JF; Chang NC; Huang CF; Wang CL; Chuang WL; Yu ML; Dai CY; Ho CK
    Kaohsiung J Med Sci; 2012 Sep; 28(9):470-6. PubMed ID: 22974665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of fatty liver disease and its risk factors in the population of South China.
    Zhou YJ; Li YY; Nie YQ; Ma JX; Lu LG; Shi SL; Chen MH; Hu PJ
    World J Gastroenterol; 2007 Dec; 13(47):6419-24. PubMed ID: 18081233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative research on obesity hypertension by the comparisons and associations between waist circumference, body mass index with systolic and diastolic blood pressure, and the clinical laboratory data between four special Chinese adult groups.
    Wu O; Leng JH; Yang FF; Yang HM; Zhang H; Li ZF; Zhang XY; Yuan CD; Li JJ; Pan Q; Liu W; Ren YJ; Liu B; Liu QM; Cao CJ
    Clin Exp Hypertens; 2018; 40(1):16-21. PubMed ID: 29083240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors of fatty liver disease in young and middle-aged population: one center study in Southwestern China.
    Xiao SJ; Fu GJ; Lv YL; Zhong XN; Wang RH
    J Gastroenterol Hepatol; 2014 Feb; 29(2):358-64. PubMed ID: 23869713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors of metabolic-associated fatty liver disease during 2014-2018 from three cities of Liaoning Province: an epidemiological survey.
    Guan L; Zhang X; Tian H; Jin X; Fan H; Wang N; Sun J; Li D; Li J; Wang X; Zeng Z; Li Y
    BMJ Open; 2022 Feb; 12(2):e047588. PubMed ID: 35177440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty liver and the metabolic syndrome among Shanghai adults.
    Fan JG; Zhu J; Li XJ; Chen L; Lu YS; Li L; Dai F; Li F; Chen SY
    J Gastroenterol Hepatol; 2005 Dec; 20(12):1825-32. PubMed ID: 16336439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and Characteristics of Metabolic Dysfunction-Associated Fatty Liver Disease among an Iranian Adult Population with Ethnic and Genetic Diversity: Results of the PolyIran-Liver Study.
    Jafari E; Merat S; Anoushiravani A; Radmard AR; Roshandel G; Sharafkhah M; Khoshnia M; Nateghi A; Shiravi Khuzani A; Poustchi H; Malekzadeh R
    Middle East J Dig Dis; 2024 Apr; 16(2):86-95. PubMed ID: 39131113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic profiles and body composition of non-obese metabolic associated fatty liver disease.
    Zhang Y; Xiang L; Qi F; Cao Y; Zhang W; Lv T; Zhou X
    Front Endocrinol (Lausanne); 2024; 15():1322563. PubMed ID: 38375190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of uric acid levels with components of metabolic syndrome and non-alcoholic fatty liver disease in overweight or obese children and adolescents.
    Cardoso AS; Gonzaga NC; Medeiros CC; Carvalho DF
    J Pediatr (Rio J); 2013; 89(4):412-8. PubMed ID: 23791233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific prevalence of fatty liver disease and associated metabolic factors in Wuhan, south central China.
    Wang Z; Xu M; Hu Z; Hultström M; Lai E
    Eur J Gastroenterol Hepatol; 2014 Sep; 26(9):1015-21. PubMed ID: 25003744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Lifestyle Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease and Its Relationship with Premature Coronary Artery Disease: A Study on the Pars Cohort.
    Anushiravani A; Rayatpisheh M; Kasaeian A; Menbari Oskouie I
    Arch Iran Med; 2024 May; 27(5):248-254. PubMed ID: 38690791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigation of metabolic disorders in patients with familial fatty liver disease and their first-degree relatives].
    Li YY; Yu Y; Wang F; Xu C; Zhang HQ; Zhao M; Liu L; Gao L; Zhao JJ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):435-40. PubMed ID: 27465947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and etiology of abnormal liver tests in an adult population in Jilin, China.
    Zhang H; He SM; Sun J; Wang C; Jiang YF; Gu Q; Feng XW; Du B; Wang W; Shi XD; Zhang SQ; Li WY; Niu JQ
    Int J Med Sci; 2011 Mar; 8(3):254-62. PubMed ID: 21487569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.